🇺🇸 FDA
Patent

US 10363213

Immunogenic composition against Campylobacter jejuni

granted A61KA61K2039/55505A61K2039/6037

Quick answer

US patent 10363213 (Immunogenic composition against Campylobacter jejuni) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55505, A61K2039/6037, A61K31/715, A61K39/105